เอกสารอ้างอิง
[1].Lexicomp, Inc. guaifenesin: Drug information. In:Post TW, ed.UpToDate.Waltham: UpToDate; 2023 (Accessed on November 27, 2023).
[2].Tietze KJ, Manaker S. Pulmonary pharmacotherapy. In: Grippi MA, Antin-Ozerkis DE, Dela Cruz CS, Kotloff RM, Kotton C, Pack AI, editors. Fishman’s pulmonary diseases and disorders 6e [Internet], McGraw Hill; 2023. [cited 2023 NOV 21]. Available from: https://accessmedicine.mhmedical.com/content.aspx?bookid=3242§ionid=270618297
[3].Calverley P, Rogliani P, Papi A. Safety of N-acetylcysteine at high doses in chronic respiratory diseases: A Review. Drug Saf. 2021;44(3):273-290.
[4].Olsson B, Johansson M, Gabrielsson J, Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol. 1988;34(1):77-82.
[5].Tenório MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF. N-Acetylcysteine (NAC): Impacts on human health. Antioxidants. 2021;10(6):967.
[6].Allen LV, Ansel HC. Ansel’s pharmaceutical dosage forms and drug delivery systems. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins. p. 214-99.